These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38116433)

  • 1. Discovery of Tumor-Targeted 6-Methyl Substituted Pemetrexed and Related Antifolates with Selective Loss of RFC Transport.
    Kaku K; Ravindra MP; Tong N; Choudhary S; Li X; Yu J; Karim M; Brzezinski M; O'Connor C; Hou Z; Matherly LH; Gangjee A
    ACS Med Chem Lett; 2023 Dec; 14(12):1682-1691. PubMed ID: 38116433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]Pyrimidine Thienoyl Antifolates.
    Wilson MR; Hou Z; Yang S; Polin L; Kushner J; White K; Huang J; Ratnam M; Gangjee A; Matherly LH
    Mol Pharmacol; 2016 Apr; 89(4):425-34. PubMed ID: 26837243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the proton-coupled folate transporter for selective delivery of 6-substituted pyrrolo[2,3-d]pyrimidine antifolate inhibitors of de novo purine biosynthesis in the chemotherapy of solid tumors.
    Desmoulin SK; Wang Y; Wu J; Stout M; Hou Z; Fulterer A; Chang MH; Romero MF; Cherian C; Gangjee A; Matherly LH
    Mol Pharmacol; 2010 Oct; 78(4):577-87. PubMed ID: 20601456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and Enzymatic Analysis of Tumor-Targeted Antifolates That Inhibit Glycinamide Ribonucleotide Formyltransferase.
    Deis SM; Doshi A; Hou Z; Matherly LH; Gangjee A; Dann CE
    Biochemistry; 2016 Aug; 55(32):4574-82. PubMed ID: 27439469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate transporter dynamics and therapy with classic and tumor-targeted antifolates.
    O'Connor C; Wallace-Povirk A; Ning C; Frühauf J; Tong N; Gangjee A; Matherly LH; Hou Z
    Sci Rep; 2021 Mar; 11(1):6389. PubMed ID: 33737637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry.
    Deng Y; Zhou X; Kugel Desmoulin S; Wu J; Cherian C; Hou Z; Matherly LH; Gangjee A
    J Med Chem; 2009 May; 52(9):2940-51. PubMed ID: 19371039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proton-coupled folate transporter: impact on pemetrexed transport and on antifolates activities compared with the reduced folate carrier.
    Zhao R; Qiu A; Tsai E; Jansen M; Akabas MH; Goldman ID
    Mol Pharmacol; 2008 Sep; 74(3):854-62. PubMed ID: 18524888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-
    Hou Z; Gattoc L; O'Connor C; Yang S; Wallace-Povirk A; George C; Orr S; Polin L; White K; Kushner J; Morris RT; Gangjee A; Matherly LH
    Mol Cancer Ther; 2017 May; 16(5):819-830. PubMed ID: 28138029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl regioisomers as inhibitors of de novo purine biosynthesis with selectivity for cellular uptake by high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier.
    Wang L; Cherian C; Kugel Desmoulin S; Mitchell-Ryan S; Hou Z; Matherly LH; Gangjee A
    J Med Chem; 2012 Feb; 55(4):1758-70. PubMed ID: 22243528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry.
    Wang L; Cherian C; Desmoulin SK; Polin L; Deng Y; Wu J; Hou Z; White K; Kushner J; Matherly LH; Gangjee A
    J Med Chem; 2010 Feb; 53(3):1306-18. PubMed ID: 20085328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors.
    Wang L; Wallace A; Raghavan S; Deis SM; Wilson MR; Yang S; Polin L; White K; Kushner J; Orr S; George C; O'Connor C; Hou Z; Mitchell-Ryan S; Dann CE; Matherly LH; Gangjee A
    J Med Chem; 2015 Sep; 58(17):6938-59. PubMed ID: 26317331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional loss of the reduced folate carrier enhances the antitumor activities of novel antifolates with selective uptake by the proton-coupled folate transporter.
    Desmoulin SK; Wang L; Polin L; White K; Kushner J; Stout M; Hou Z; Cherian C; Gangjee A; Matherly LH
    Mol Pharmacol; 2012 Oct; 82(4):591-600. PubMed ID: 22740639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of amide-bridged pyrrolo[2,3-d]pyrimidines as tumor targeted classical antifolates with selective uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis.
    Xiang W; Dekhne A; Doshi A; O'Connor C; Hou Z; Matherly LH; Gangjee A
    Bioorg Med Chem; 2019 Dec; 27(23):115125. PubMed ID: 31679978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter.
    Cherian C; Kugel Desmoulin S; Wang L; Polin L; White K; Kushner J; Stout M; Hou Z; Gangjee A; Matherly LH
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):999-1011. PubMed ID: 23412628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits β-glycinamide ribonucleotide formyltransferase.
    Wang L; Desmoulin SK; Cherian C; Polin L; White K; Kushner J; Fulterer A; Chang MH; Mitchell-Ryan S; Stout M; Romero MF; Hou Z; Matherly LH; Gangjee A
    J Med Chem; 2011 Oct; 54(20):7150-64. PubMed ID: 21879757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.
    Matherly LH; Wilson MR; Hou Z
    Drug Metab Dispos; 2014 Apr; 42(4):632-49. PubMed ID: 24396145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrier.
    Golani LK; Islam F; O'Connor C; Dekhne AS; Hou Z; Matherly LH; Gangjee A
    Bioorg Med Chem; 2020 Jun; 28(12):115544. PubMed ID: 32503687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.
    Hou Z; Matherly LH
    Curr Top Membr; 2014; 73():175-204. PubMed ID: 24745983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and therapeutic applications of the proton-coupled folate transporter.
    Matherly LH; Schneider M; Gangjee A; Hou Z
    Expert Opin Drug Metab Toxicol; 2022 Oct; 18(10):695-706. PubMed ID: 36239195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.
    Matherly LH; Hou Z; Gangjee A
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):1-15. PubMed ID: 29127457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.